Already validated through gold-standard clinical evidence demonstrating its benefits in seniors, and students, Memophenol™’s double-patented formula has consistently shown its ability to slow cognitive decline and enhance cognitive performance. These new findings confirm its relevance for an even younger demographic, marking an important step in broadening its application across the full spectrum of cognitive needs.
As academic expectations grow more demanding, children today must sustain focus, process information quickly, regulate emotions, and adapt to continuous learning challenges. Many parents report rising concerns around attention, memory, and behavioural regulation—skills essential for success both inside and outside the classroom.
This trend is reflected in market dynamics: Between 2020 and 2024, the global children’s brain-health supplements category surged from USD 5.61 million to USD 7,235.6 million (1), driven by rising awareness of early cognitive development and growing pediatrician-recommended supplementation. Families now seek solutions that not only support general wellness but offer science-backed benefits on memory, focus, and executive functions.
Memophenol™: A scientifically validated cognitive solution
Developed through the rigorous four-year international research program, Memophenol™ is supported by gold-standard clinical evidence demonstrating the effectiveness of its double-patented formula in slowing cognitive aging and improving cognitive performance. Its pharmaceutical-like development has garnered multiple international awards and widespread scientific recognition, including three gold-standard clinical studies and coverage in the esteemed Journal of the American Medical Association (JAMA).
Building on this strong evidence base in adults, Activ’Inside has extended its scientific efforts to the pediatric population through a new real-world study dedicated to children.
A new real-world study focused on children’s cognitive performance
This newly completed investigation evaluates how Memophenol™ may support cognitive functions crucial for academic and emotional development—including memory, attention, and information processing—with a new focus on children.
Upcoming webinar: scientific insights & results
To accompany the release of this new data, Activ’Inside will host an expert-led webinar exploring:
- What nootropics are and how they may support children’s daily learning and focus
- The importance of early brain development and its long-term impact on learning
- How a clinically proven formula like Memophenol™ can address children’s cognitive needs by enhancing key mechanisms related to memory
- Exclusive findings from the new real-world study conducted in children
This session will provide researchers, health professionals, and industry leaders with insight into a promising natural solution for children’s cognitive support.
Date: 11 December 2025
Time: 10h30-11 :30 (UTC+1)
Link: https://events.teams.microsoft.com/event/c81902c3-a1f9-476f-a60f-2ae825765c33@88fb648b-2f72-40b1-9345-728aff508393
Reference
1. Kids’ Brain Health Supplements Market Global Demand by 2035
This product is not intended to treat, cure, diagnose or prevent any disease. Regulations concerning messages and claims that can be placed on packaging may differ depending on the country of sale. The marketer must ensure that the information displayed is in accordance with the applicable regulations in each country where the finished product is marketed.
